Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cimetidine and Ranitidine on Tiotropium PK
NCT02172417Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2000
- Primary completion
- Nov 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve 0-4h and 2 more. Started Jul 2000; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172417.